NCT04298892 2024-07-01
INTHEMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Unknown
Clinical Trials
22 trialsNCT04601584 2024-03-06
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
AO GENERIUM
Phase 1/2 Unknown
NCT05280275 2023-12-01
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible
Hellenic Society of Hematology
Phase 1/2 Unknown
NCT05755854 2023-09-22
Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors
Anhui Provincial Hospital
Phase 1 Unknown
NCT05983536 2023-08-09
The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)
Qianfoshan Hospital
Unknown
NCT04309084 2023-02-16
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
Celularity Incorporated
Phase 1 Unknown
NCT05080907 2022-11-09
Collection and Distribution of Biospecimens for Novel Research
iSpecimen Inc
Unknown
NCT05147493 2022-03-29
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment
Hellenic Society of Hematology
Phase 2 Unknown
NCT05298683 2022-03-28
A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor
Hellenic Society of Hematology
Phase 2 Unknown
NCT04720144 2021-02-09
BIMI
Centre Hospitalier Universitaire Vaudois
Unknown
NCT04243434 2020-04-16
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Acrotech Biopharma Inc.
Phase 1 Unknown
NCT02380378 2019-04-02
MPN
Hospital Israelita Albert Einstein
Unknown
NCT03868527 2019-03-11
Arcan database
Hospices Civils de Lyon
Unknown
NCT03272789 2019-01-23
REBOND
Institut Paoli-Calmettes
Phase NA Unknown
NCT03674164 2018-09-17
PTO
St. Justine's Hospital
Phase NA Unknown
NCT03556748 2018-06-14
WB-EMS and Nutrition in Patients With Hematological Malignancies
University of Erlangen-Nürnberg Medical School
Phase NA Unknown
NCT02806791 2016-06-21
Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment
Azienda Ospedaliera San Giovanni Battista
Unknown
NCT02456818 2016-02-08
CONTAIN
University of Cologne
Unknown
NCT01435720 2014-09-11
Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)
Senesco Technologies, Inc.
Phase 1/2 Unknown
NCT00866762 2011-12-12
A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia
Copenhagen University Hospital at Herlev
Phase 2 Unknown
NCT00883961 2009-12-23
Exercise Following Autologous Peripheral Blood Stem Cell Transplantation
Charite University, Berlin, Germany
Phase 3 Unknown
NCT00884364 2009-12-23
Exercise During Chemotherapy for Patients With Hematological Malignancies
Charite University, Berlin, Germany
Phase 3 Unknown